RNCOS Releases Report on Booming Clinical Trials Market in India
Released on: February 5, 2008, 3:39 am
Press Release Author: Shushmul Maheshwari
Industry: Biotech
Press Release Summary: The market research company RNCOS has recently released a report “Booming Clinical Trials Market in India” to give first-hand information on the emerging Indian clinical trials market.
Press Release Body: The market research company RNCOS has recently released a report “Booming Clinical Trials Market in India” to give first-hand information on the emerging Indian clinical trials market. It investigates the key competitive advantages/disadvantages India has in the field of conducting clinical trials and does a thorough study of the key factors impacting the country’s clinical trials, such as patient pool, patient recruitment, cost, time, government regulations, intellectual property, human resources, infrastructure and ethical issues.
Market Analysis
India, with its huge patient base, low cost advantage, completion of clinical trials on time, improving infrastructure, and with a strong government support is witnessing a double digit growth in its clinical trials market. All major pharmaceutical companies and Clinical Research Organizations (CROs) have already started conducting their clinical trials in India, and with improving infrastructure, industry friendly regulations and trained workforce, the growth is only likely to increase in future.
However, to achieve its goal of becoming a global hub of clinical trials, the country will have to overcome challenges like unethical trials, delay in trial approval, inappropriate protection of clinical data, and lack of Good Clinical Practice (GCP) certified sites and investigators.
Key Issues and Facts Analyzed
- Evaluation of past, current and future market trends. - Discussion about the factors driving the clinical research market. - An analysis of the opportunities created by the market. - A review on the government regulations on the market. - An analysis of the major challenges faced by the market.
Key Players Analyzed
This section provides the overview, key facts financial information of prominent players in the Indian clinical trials market like Quintiles, Ranbaxy, Dr Reddy’s Laboratories, Roche, Pfizer etc.
Research Methodology Used
Information Sources
Information has been sourced from books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis. For more information visit: http://www.rncos.com/Report/IM564.htm Current Industry News: http://www.rncos.com/Blog/
2025
